Bangladesh Bank has imposed new restrictions on the import of supplement products in foreign currency transactions.
From now on, no importing company will be able to open LC or Telegraphic Transfer (TT) for the import of dietary, herbal or nutritional supplements without registration or prior approval of the Drug Administration.
The directive was given in a circular issued by the Foreign Exchange Policy Department on Wednesday (April 29).
The central bank said that the decision was taken in light of a letter from the Health Services Division of the Ministry of Health and Family Welfare.
The relevant letter states that, according to the 'Drugs and Cosmetics Act, 2023', registration or prior approval of the Directorate of Drug Administration is mandatory for the production, import, export, sale and distribution of all types of dietary supplements, herbal supplements, medical nutrition and other supplementary food products.
Violation of this provision will be considered a punishable offense.
However, in reality, it has been seen that some importing companies have imported supplement products from abroad without this approval.
Later, when the customs authorities blocked the release of these products, the concerned parties filed a writ in the High Court.
After the court's instructions and subsequent appeal process, the opportunity to release the products was given on the condition of "according to law".
In this situation, to ensure public interest and law enforcement, the Directorate of Drug Administration requested Bangladesh Bank so that LC or TT are not opened for the import of supplement products without registration or prior approval.
In view of this, the central bank has ordered all the banks concerned to take necessary measures.
Concerned people say that the new directive will reduce irregularities in the import of supplements and make it possible to control the entry of substandard or unauthorized products into the market.
At the same time, it will also play an important role in protecting public health.